CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Regulation FD disclosure
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market sale Chief Executive Officer sold 19,608 shares at $5.16 ($101,091)
- 4 Open-market sale Chief Financial Officer sold 9,191 shares at $5.16 ($47,385)
- 4 Open-market sale SVP, Chief Legal Officer sold 6,727 shares at $5.16 ($34,682)
- 4 Open-market sale Chief Commercial Officer sold 4,902 shares at $5.16 ($25,273)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Director sold 15,000 shares at $5.86 ($87,966)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Financial Officer sold 1,478 shares at $6.53 ($9,651)
Page 1 of 66 · 1,318 filings